Editors' Pick A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod. Koch-Henriksen N, Magyari M, Sellebjerg F, Sørensen P S Mult Scler. 2016 Apr 7. Epub 1969 Dec 31. PMID: 27055806. Abstract CommentRecommendBookmarkWatch